Active ingredients: Cisatracurium
Nimbex 2mg/ml solution for injection/infusion.
Solution for injection/infusion.
Colourless to pale yellow or greenish yellow solution. Practically free from visible particulate matter.
Cisatracurium 2mg as cisatracurium besilate 2.68mg per 1ml.
One ampoule of 2.5ml contains 5mg of cisatracurium.
One ampoule of 5ml contains 10mg of cisatracurium.
One ampoule of 10ml contains 20mg of cisatracurium.
One ampoule of 25ml contains 50mg of cisatracurium.
For excipients, see Section 6.1.
Cisatracurium is an intermediate-duration, non-depolarising benzylisoquinolinium skeletal muscle relaxant.
Benzene sulfonic acid solution 32% w/v
Water for injections
Nimbex 2mg/ml solution for injection/infusion.
2.5ml in ampoule (glass): box of 5
5ml in ampoule (glass): box of 5
10ml in ampoule (glass): box of 5
25ml in ampoule (glass: box of 2
Type I, clear, neutral glass ampoules.
NOT ALL PACK SIZES MAY BE MARKETED
The Wellcome Foundation Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Trading as:
GlaxoSmithKline UK
Stockley Park West
Uxbridge
Middlesex
UB11 1BT
Date of first authorisation: 07 August 1995
Date of last renewal: 09 August 2010
PL 00003/0364